Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

PHASE3CompletedINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Squamous Cell Lung Cancer
Interventions
DRUG

gemcitabine/carboplatin

i.v.

DRUG

gemcitabine/carboplatin plus Iniparib

i.v.

Trial Locations (142)

1090

Investigational Site Number 056003, Brussels

1121

Investigational Site Number 348005, Budapest

1210

Investigational Site Number 442001, Luxembourg

1529

Investigational Site Number 348003, Budapest

3233

Investigational Site Number 348001, Mátraháza

4000

Investigational Site Number 056001, Liège

4400

Investigational Site Number 348004, Nyíregyháza

8310

Investigational Site Number 056004, Bruges

10043

Investigational Site Number 380008, Orbassano

13008

Investigational Site Number 250003, Marseille

13125

Investigational Site Number 276004, Berlin

15006

Investigational Site Number 724004, A Coruña

16132

Investigational Site Number 380006, Genova

19611

Investigational Site Number 840211, West Reading

19713

Investigational Site Number 840315, Newark

20817

Investigational Site Number 840202, Bethesda

21034

Investigational Site Number 250002, Dijon

21801

Investigational Site Number 840345, Salisbury

22927

Investigational Site Number 276008, Großhansdorf

23230

Investigational Site Number 840102, Richmond

23601

Investigational Site Number 840219, Newport News

26121

Investigational Site Number 276003, Oldenburg

26506

Investigational Site Number 840322, Morgantown

27599

Investigational Site Number 840350, Chapel Hill

27710

Investigational Site Number 840330, Durham

28034

Investigational Site Number 724005, Madrid

28041

Investigational Site Number 724006, Madrid

28100

Investigational Site Number 380001, Novara

29011

Investigational Site Number 724002, Málaga

29210

Investigational Site Number 840106, Columbia

29303

Investigational Site Number 840220, Spartanburg

29403

Investigational Site Number 840352, Charleston

29609

Investigational Site Number 250007, Brest

30045

Investigational Site Number 840301, Lawrenceville

30060

Investigational Site Number 840305, Marietta

30084

Investigational Site Number 840314, Tucker

30501

Investigational Site Number 840201, Gainesville

30607

Investigational Site Number 840343, Athens

30901

Investigational Site Number 840213, Augusta

Investigational Site Number 840347, Augusta

32256

Investigational Site Number 840215, Jacksonville

32804

Investigational Site Number 840205, Orlando

33308

Investigational Site Number 840216, Fort Lauderdale

33805

Investigational Site Number 840217, Lakeland

34236

Investigational Site Number 840104, Sarasota

34376

Investigational Site Number 276009, Immenhausen

35205

Investigational Site Number 840306, Birmingham

35661

Investigational Site Number 840351, Muscle Shoals

35805

Investigational Site Number 840207, Huntsville

37044

Investigational Site Number 250005, Tours

37203

Investigational Site Number 840101, Nashville

37404

Investigational Site Number 840103, Chattanooga

Investigational Site Number 840208, Chattanooga

38017

Investigational Site Number 840203, Collierville

40202

Investigational Site Number 840320, Louisville

41013

Investigational Site Number 724008, Seville

43219

Investigational Site Number 840335, Columbus

44106

Investigational Site Number 840302, Cleveland

44195

Investigational Site Number 840348, Cleveland

44281

Investigational Site Number 376002, Kfar Saba

44805

Investigational Site Number 250001, Saint-Herblain

45242

Investigational Site Number 840105, Cincinnati

46014

Investigational Site Number 724010, Valencia

46260

Investigational Site Number 840319, Indianapolis

46601

Investigational Site Number 840329, South Bend

47630

Investigational Site Number 840218, Evansville

48073

Investigational Site Number 840337, Royal Oak

49100

Investigational Site Number 376005, Petah Tikva

50009

Investigational Site Number 724007, Zaragoza

52621

Investigational Site Number 376003, Tel Litwinsky

53226

Investigational Site Number 840331, Wauwatosa

55426

Investigational Site Number 840328, Saint Louis Park

60153

Investigational Site Number 840327, Maywood

60488

Investigational Site Number 276007, Frankfurt am Main

60637

Investigational Site Number 840313, Chicago

63044

Investigational Site Number 840210, Bridgeton

67100

Investigational Site Number 250006, Strasbourg

67214

Investigational Site Number 840316, Wichita

68114

Investigational Site Number 840212, Omaha

69126

Investigational Site Number 276012, Heidelberg

69495

Investigational Site Number 250010, Pierre-Bénite

70300

Investigational Site Number 376001, Tzrifin

73112

Investigational Site Number 840341, Concord

74245

Investigational Site Number 276001, Löwenstein

75651

Investigational Site Number 250004, Paris

76104

Investigational Site Number 840323, Fort Worth

80205

Investigational Site Number 840336, Denver

80336

Investigational Site Number 276006, München

86021

Investigational Site Number 250008, Poitiers

87042

Investigational Site Number 250009, Limoges

89135

Investigational Site Number 840318, Las Vegas

91010

Investigational Site Number 840317, Duarte

91505

Investigational Site Number 840353, Burbank

91750

Investigational Site Number 840339, La Verne

92123

Investigational Site Number 840303, San Diego

92224

Investigational Site Number 276002, Amberg

92354

Investigational Site Number 840309, Loma Linda

92801

Investigational Site Number 840338, Anaheim

94589

Investigational Site Number 840310, Vallejo

95204

Investigational Site Number 840326, Stockton

95403

Investigational Site Number 840321, Santa Rosa

97701

Investigational Site Number 840311, Bend

98104

Investigational Site Number 840312, Seattle

98405

Investigational Site Number 840344, Tacoma

200385

Investigational Site Number 642004, Craiova

331057

Investigational Site Number 642005, Hunedoara

400015

Investigational Site Number 642001, Cluj-Napoca

510077

Investigational Site Number 642002, Alba Iulia

90095-7059

Investigational Site Number 840307, Los Angeles

06360

Investigational Site Number 840346, Norwich

04074-9308

Investigational Site Number 840308, Scarborough

07960

Investigational Site Number 840204, Morristown

T6G 1Z2

Investigational Site Number 124003, Edmonton

J4V 2H1

Investigational Site Number 124006, Greenfield Park

N6A 4L6

Investigational Site Number 124005, London

L1G 2B9

Investigational Site Number 124007, Oshawa

G1V 4G5

Investigational Site Number 124004, Québec

M5G 2M9

Investigational Site Number 124001, Toronto

06120

Investigational Site Number 276010, Halle

06128

Investigational Site Number 380002, Perugia

00149

Investigational Site Number 380003, Roma

00189

Investigational Site Number 380007, Roma

4818 CK

Investigational Site Number 528005, Breda

5623 EJ

Investigational Site Number 528004, Eindhoven

9713 GZ

Investigational Site Number 528001, Groningen

6229 HX

Investigational Site Number 528006, Maastricht

8011 JW

Investigational Site Number 528003, Zwolle

15-069

Investigational Site Number 616006, Bialystok

31 -202

Investigational Site Number 616001, Krakow

59-300

Investigational Site Number 616007, Lubin

10-228

Investigational Site Number 616004, Olsztyn

87-100

Investigational Site Number 616008, Torun

02-781

Investigational Site Number 616002, Warsaw

53-439

Investigational Site Number 616005, Wroclaw

022328

Investigational Site Number 642006, Bucharest

08916

Investigational Site Number 724009, Badalona

08035

Investigational Site Number 724003, Barcelona

07198

Investigational Site Number 724001, Palma de Mallorca

G12 0YN

Investigational Site Number 826002, Glasgow

LS9 7TF

Investigational Site Number 826005, Leeds

M20 4BX

Investigational Site Number 826001, Manchester

WV10 0QP

Investigational Site Number 826006, Wolverhampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY